The European Commission has re-issued for consultation its draft guidance on good manufacturing practices for advanced therapy medicinal products, after modifying the document to address comments raised during a 2015 consultation of the guideline.
The new draft is more extensive than the previous document, Barbara Freischem, executive director of the European Biopharmaceutical Enterprises (EBE)...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?